Many ranitidine products – including the Zantac brand – have been subject to a TGA recall notice following concerns about contamination with potentially carcinogen nitrosomamine . The TGA is advising health professional to expect shortages of ranitidine products following their withdrawal from sale in pharmacies, hospitals, wholesalers, and other retail outlets, such as supermarkets. “Doctors ...
Ranitidine products withdrawn due to carcinogenic impurities
By Michael Woodhead
24 Oct 2019